| Code | Description | Claims | Beneficiaries | Total Paid |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
286 |
274 |
$12K |
| 87040 |
|
620 |
325 |
$4K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
684 |
499 |
$2K |
| 87486 |
|
98 |
67 |
$664.10 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
97 |
66 |
$641.65 |
| 87581 |
|
97 |
66 |
$641.20 |
| 87631 |
|
99 |
68 |
$600.00 |
| 87186 |
|
287 |
186 |
$570.65 |
| 87205 |
|
315 |
175 |
$238.00 |
| 87070 |
|
185 |
119 |
$179.80 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
15 |
12 |
$68.70 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
16 |
13 |
$68.70 |
| 87081 |
|
65 |
45 |
$23.20 |
| 87147 |
|
20 |
13 |
$20.80 |
| 87077 |
|
189 |
146 |
$0.00 |